ABBV
AbbVie Inc
AbbVie Inc historical holders
total: 14
Jensen Investment Management AbbVie Inc transactions over time
- Total transactions:
- 30
- New positions:
- 1
- Added:
- 2
- Reduced:
- 27
- Held since:
- 2013 Q2 or earlier
- Held for:
- 52+ quarters
- Latest activity:
- 2025 Q4
Eric H. Schoenstein has been an institutional investor in AbbVie Inc (ABBV) since at least 2013 Q2. According to 2026 Q1 report, Eric H. Schoenstein holds 11,144 shares with a market value of roughly $2.42M representing 0.05% of their equity portfolio. In our earliest available record from 2013 Q2, Jensen Investment Management held 43,641 shares of ABBV. Since at least 2013 Q2, Jensen Investment Management has made 29 more transactions in this position.
Does Eric H. Schoenstein still hold ABBV?
Yes, Eric H. Schoenstein continues to hold AbbVie Inc (ABBV). According to their 2026 Q1 report, they maintain a position of 11,144 shares valued at approximately $2.42M, representing 0.05% of their equity portfolio.
Estimated cost basis*
- Weighted AVG buy price:
- $42.18
- Weighted AVG sell price:
- $127.65
ABBV transactions history by Jensen Investment Management
30 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q4
|
0.04%
|
11,144
|
$228.49
|
$2,546,293
|
-38.51% (-6,978)
|
-0.02%
|
|
2025 Q3
|
0.05%
|
18,122
|
$231.54
|
$4,195,968
|
-18.47% (-4,105)
|
-0.01%
|
|
2024 Q1
|
0.03%
|
22,227
|
$182.10
|
$4,047,537
|
-0.04% (-10)
|
-0%
|
|
2023 Q3
|
0.03%
|
22,237
|
$149.06
|
$3,314,647
|
-0.58% (-130)
|
-0%
|
|
2023 Q2
|
0.02%
|
22,367
|
$134.73
|
$3,013,506
|
-6.28% (-1,500)
|
-0%
|
|
2022 Q4
|
0.03%
|
23,867
|
$161.61
|
$3,857,146
|
-0.38% (-90)
|
-0%
|
|
2022 Q2
|
0.03%
|
23,957
|
$153.15
|
$3,669,000
|
+1.27% (+300)
|
+0%
|
|
2021 Q4
|
0.02%
|
23,657
|
$135.39
|
$3,203,000
|
-2.07% (-500)
|
-0%
|
|
2021 Q3
|
0.02%
|
24,157
|
$107.88
|
$2,606,000
|
-0.41% (-100)
|
-0%
|
|
2021 Q1
|
0.02%
|
24,257
|
$108.22
|
$2,625,000
|
-4.71% (-1,200)
|
-0%
|
|
2020 Q4
|
0.02%
|
$107.16
|
+0.20% (+52)
|
|||
|
2019 Q2
|
0.02%
|
$72.70
|
-0.78% (-200)
|
|||
|
2019 Q1
|
0.02%
|
$80.61
|
-5.88% (-1,600)
|
|||
|
2018 Q4
|
0.04%
|
$92.19
|
-0.48% (-130)
|
|||
|
2018 Q2
|
0.03%
|
$92.67
|
-0.24% (-65)
|
|||
|
2018 Q1
|
0.03%
|
$94.64
|
-3.86% (-1,100)
|
|||
|
2017 Q4
|
0.04%
|
$96.70
|
-0.94% (-270)
|
|||
|
2017 Q3
|
0.03%
|
$88.88
|
-4.80% (-1,450)
|
|||
|
2017 Q2
|
0.03%
|
$72.50
|
-0.98% (-300)
|
|||
|
2017 Q1
|
0.03%
|
$65.17
|
-1.61% (-500)
|
|||
|
2016 Q4
|
0.03%
|
$62.60
|
-1.27% (-400)
|
|||
|
2016 Q1
|
0.03%
|
$57.13
|
-0.16% (-50)
|
|||
|
2015 Q3
|
0.03%
|
$54.40
|
-7.63% (-2,600)
|
|||
|
2015 Q1
|
0.03%
|
$58.53
|
-5.33% (-1,917)
|
|||
|
2014 Q4
|
0.04%
|
$65.44
|
-10.08% (-4,033)
|
|||
|
2014 Q3
|
0.04%
|
$57.77
|
-2.11% (-863)
|
|||
|
2014 Q1
|
0.03%
|
$51.39
|
-1.92% (-800)
|
|||
|
2013 Q4
|
0.03%
|
$52.80
|
-0.94% (-397)
|
|||
|
2013 Q3
|
0.03%
|
$44.72
|
-3.58% (-1,561)
|
|||
|
2013 Q2
|
0.03%
|
$41.34
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.